All conditions

Tuberculosis

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

1542
Trials on record
149
Recruiting now
1
Australian sites
22
Phase 3 trials
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Tuberculosis →

Get alerts when Tuberculosis trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Tuberculosis (TB)

Tuberculosis, often called TB, is an infectious disease caused by a type of bacteria called Mycobacterium tuberculosis. It most commonly affects the lungs, but it can also affect other parts of the body such as the lymph nodes, kidneys, spine, or brain. TB spreads through the air when a person with active TB in their lungs coughs, sneezes, or speaks, and someone nearby breathes in those tiny droplets. It is important to know that not everyone who is exposed to TB bacteria becomes unwell. Some people develop what is called latent TB, where the bacteria are present in the body but inactive, causing no symptoms and posing no risk to others. Others develop active TB, which does cause symptoms and can be passed on.

In Australia, TB is not as common as it is in many other parts of the world, but it does still occur. Each year, a few hundred cases are diagnosed across the country. TB is more commonly diagnosed in people who were born overseas, particularly those who have come from countries where TB is more widespread, as well as in some Aboriginal and Torres Strait Islander communities. People with weakened immune systems, such as those living with HIV or taking certain medications, may also have a higher risk.

The good news is that TB is treatable. Standard treatment involves taking a course of antibiotics, which usually lasts several months. Because the bacteria can be stubborn, a combination of different antibiotic medicines is typically used together rather than just one. It is generally very important that the full course of treatment is completed, even if a person starts to feel better earlier, to make sure the bacteria are fully cleared. In Australia, TB treatment and monitoring are usually managed by specialist public health or infectious disease services, and support is available to help people through the process.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Tuberculosis in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

Research pipeline

Where trials for Tuberculosis currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Tuberculosis.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Tuberculosis by country. Australia is highlighted.

Showing the top 10 of 58 countries with trial sites.

Clinical trials for Tuberculosis

Showing 149 of 149 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT03474029 · Centers for Disease Control and Prevention Phase 3 · 8 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2029
🇦🇺 AU Benin🇨🇦 CA Haiti🇿🇦 ZA Uganda🇺🇸 US🇻🇳 VN

**Who might be able to join this trial:** - People who have a latent TB infection (meaning they carry the TB bacteria but do not have active TB disease), shown by a positive skin test or blood test, and who are at higher risk of developing active TB due to at least one of the following reasons: - People who have spent...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT01212003 · National Institute of Allergy and Infectious Diseases (NIAID) Not Applicable · 1 country Recruiting
Recruiting Not Applicable
🇺🇸 US

Who might be able to join this trial: - People who have, or are suspected to have, a tuberculosis (TB) infection. - People aged 2 years or older. - People who have a doctor outside of the NIH (such as a family doctor, lung specialist, or TB specialist) who can manage their TB care, oversee their medication-taking if ne...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02354014 · Janssen Research & Development, LLC Phase 2 · 6 countries Recruiting
Recruiting Phase 2 Est. completion 11 February 2027
Mozambique🇵🇭 PH🇷🇺 RU🇿🇦 ZA Uganda🇺🇦 UA

**Who might be able to join this trial:** - You must be a boy or girl aged from birth up to (but not including) 18 years old at the time of screening; if you are in the youngest age group and under 6 months old, you must have been born at full term (at least 37 weeks of pregnancy) - You must weigh more than 3 kilogram...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02454569 · Rural Development Trust Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2039
🇮🇳 IN

Who might be able to join this trial: - You have tested positive for HIV (confirmed through a blood test) Who may not be able to join: - You are not willing to give your consent to take part in the trial Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02527486 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2021
🇰🇷 KR

Who might be able to join this trial: **For people with COPD:** - People who have been diagnosed with COPD, shown by a specific breathing test result (where the airways are significantly narrowed after using a reliever inhaler) and who have ongoing breathing symptoms. **For people with Asthma:** - People who have nev...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03044509 · University Children's Hospital Basel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇭 CH

Who might be able to join this trial: - Children and teenagers under 18 years old who are currently being assessed for possible tuberculosis (TB) exposure, infection, or disease. Who may not be able to join: - Children or teenagers who have already started taking medication to treat TB infection or disease. - Children...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03159364 · Shenzhen Geno-Immune Medical Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2029
🇨🇳 CN

Who might be able to join this trial: - You have evidence of infection with one of these viruses: CMV, EBV, ADV, BKV, or another known virus (confirmed by a lab test), and standard antiviral medicines have not worked or cannot be used. - Your virus levels in the blood have been rising across two blood tests taken at le...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03625739 · Beijing Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - Children aged 0 to 18 years old who are receiving treatment for tuberculosis (TB) - Children whose TB treatment includes drugs commonly used in children's infectious diseases - Children whose parents and/or guardians have signed a consent form agreeing to take part **Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03691883 · Fundació Institut Germans Trias i Pujol Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - People who have been diagnosed with tuberculosis (TB) in any form, confirmed by a laboratory test (such as a microscopy test, GenXpert test, or culture test) - People whose TB care is being managed at one of these specific hospitals: Servicios Clínicos at Hospital Universitari Va...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04052022 · National Institute of Allergy and Infectious Diseases (NIAID) Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 April 2029
🇲🇽 MX🇺🇸 US

**Who might be able to join this trial:** *For people experiencing a possible paradoxical reaction (worsening symptoms during or after TB treatment):* - You are 18 years of age or older - You have been diagnosed with TB (confirmed by a lab test or suspected based on symptoms/tissue examination) and have been on TB tre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04145258 · ANRS, Emerging Infectious Diseases Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 23 September 2026
Côte d’Ivoire Madagascar🇿🇦 ZA Uganda

Who might be able to join this trial: - People aged 15 years or older - People who have been diagnosed with tuberculous meningitis (a serious brain infection caused by tuberculosis), confirmed or suspected based on specific medical test results or scoring systems (confirm with trial site) - People who have provided sig...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04147286 · University of Cape Town Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 September 2025
🇿🇦 ZA

**Who might be able to join this trial:** - You have read and signed a consent form before any screening, and you are willing to have an HIV test - You are between 18 and 65 years old and weigh between 50 kg (110 lbs) and 90 kg (198 lbs) - Your TB treatment worked well and your sputum (mucus) test came back negative a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04260477 · Institute of Tropical Medicine, Belgium Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 June 2025
Niger

Who might be able to join this trial: - People who have been newly diagnosed with a recurring (came back) form of tuberculosis (TB) that affects the lungs, confirmed by a sputum smear test - People of any age, including both adults and children, may be considered - People who are able and willing to sign a written cons...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04271397 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 September 2026
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have given written agreement to take part in the trial - People who are willing to attend follow-up appointments for at least 6 months - People with confirmed active tuberculosis (TB), shown through a positive lab test and/or a positive PC...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04521803 · University of Cape Town Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 September 2025
🇿🇦 ZA

**Who might be able to join this trial:** - Adults aged over 18 years - People with suspected tuberculosis of the sac around the heart (pericardium), with fluid around the heart confirmed by an ultrasound scan (echocardiogram) - People who agree to take part in the study, including agreeing to an HIV test if their HIV...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04700579 · University of Stellenbosch Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇿🇦 ZA

**Who might be able to join this trial:** - You are between 18 and 60 years old. - You are willing to have a chest X-ray and/or CT scan. - You have TB affecting only one lung (this requirement does not apply to healthy participants joining as controls; participants joining as "sick controls" will need a different diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04923958 · University of California, San Francisco Not Applicable · 8 countries Recruiting
Recruiting Not Applicable Est. completion 31 May 2031
🇬🇪 GE🇮🇳 IN Nigeria🇵🇭 PH🇿🇦 ZA Uganda🇻🇳 VN Zambia

**Who might be able to join this trial:** *For the new TB testing study:* - You are 12 years old or older and are not currently staying in a hospital - You have had a cough lasting 2 weeks or longer, OR you have a risk factor for TB (such as being HIV-positive, having been in close contact with someone who had TB, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04975178 · Biofabri, S.L Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 February 2029
🇿🇦 ZA

**Who might be able to join this trial:** - The baby must be male or female and enrolled within the first seven days after birth. - The mother must give written permission for her baby to take part, including allowing access to her own and her baby's medical records. - The family must be willing and able to attend fol...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05022238 · University of Namibia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
Namibia

Who might be able to join this trial: - People in Namibia who have been diagnosed with tuberculosis (TB) that is resistant to standard medicines, living in one of three regions: Khomas, Otjozondjupa, or Ohangwena - People who live in the same household as someone with drug-resistant TB in those regions - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05022862 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with latent TB (an inactive TB infection) and your doctor has decided that treatment is right for you - You live in the Baltimore metro area - You speak English, Spanish, or another language for which a translated consen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05069688 · Brigham and Women's Hospital Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
Nigeria

Who might be able to join this trial: - Children living with HIV who are between 4 weeks and under 6 years of age, whether or not they have previously received HIV treatment - Children who have been diagnosed with active tuberculosis (TB) - Children who weigh at least 3 kilograms - Children whose parent or legal guardi...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05081401 · Huashan Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 16 to 75 years, male or female, who weigh more than 30kg, regardless of whether they have HIV - People who have been diagnosed with tuberculosis (TB) in the lungs that is resistant to the antibiotic rifampicin, confirmed by an approved test within the last 60 days...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05285202 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Uganda

Who might be able to join this trial: - People aged 15 years or older, OR children aged 5 to 14 years who have been in close contact with someone diagnosed with tuberculosis (TB) - People who are able to give spoken agreement to take part — or, for children under 18 who are not legally independent, a parent or guardian...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05317247 · University of Stellenbosch Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇿🇦 ZA Uganda

Who might be able to join this trial: - People who are at least 12 years old - People who have had a persistent cough lasting at least two weeks - People who are willing to provide informed consent (agreement to participate) - People who either already know their HIV status or are willing to have standard HIV testing a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05381194 · Asan Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇰🇷 KR

**Who might be able to join this trial:** - You are at least 19 years old when you sign up for the trial - You weigh more than 35 kg (about 77 lbs) - Your TB has been confirmed through a lab test (on a sputum or lung sample taken within the last 3 months) to be resistant to a key TB antibiotic called rifampicin - A che...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05383742 · National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 · 12 countries Recruiting
Recruiting Phase 2 Est. completion 30 April 2028
🇧🇷 BR🇮🇳 IN Kenya Malawi🇲🇽 MX🇵🇪 PE🇵🇭 PH🇿🇦 ZA +4 more

**Who might be able to join this trial:** - People who have been diagnosed with tuberculous meningitis (a type of brain infection caused by TB) — whether that diagnosis is confirmed, probable, or possible — and who are already receiving or committed to receiving a full course of standard TB treatment as part of their...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05401071 · Huashan Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 October 2024
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 60 years old - People who weigh between 40 and 80 kilograms - People who have been diagnosed with pulmonary (lung) tuberculosis that shows up on a sputum smear test and responds to the antibiotic rifampicin - People who are willing to sign a consent...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05426720 · Peking University Third Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

**Who might be able to join this trial:** - You are male and between 25 and 60 years old - You have recently been diagnosed with active tuberculosis (TB) affecting the lungs **Who may not be able to join:** - Your sputum (mucus/phlegm) test or TB lab culture came back positive - You are HIV-positive - You have a type...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05473520 · National University Hospital, Singapore Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 31 January 2030
🇲🇾 MY🇸🇬 SG

**Who might be able to join this trial:** - People aged 21 years or older - People who have been receiving tuberculosis (TB) treatment for 14 days or fewer, or who are about to start standard TB treatment - People with confirmed TB in the lungs, shown by positive laboratory test results (such as a smear test, a DNA-bas...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05493267 · Shanghai Pulmonary Hospital, Shanghai, China Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 3 August 2025
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with tuberculosis (TB) that is resistant to at least two common TB antibiotics (isoniazid and rifampicin), known as drug-resistant TB or MDR-TB. - Your current TB treatment is not working well, you are not responding to treatment at all, or there are fewer...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05534750 · Assistance Publique - Hôpitaux de Paris Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 April 2026
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 years or older but younger than 75 years old - Women of childbearing age who are willing and able to use effective contraception (with a condom strongly recommended) for the full length of the study and for 6 months after treatment ends - Men who are willing and ab...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05539014 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2027
🇫🇷 FR

Who might be able to join this trial: - People who are being treated for tuberculosis (TB) — either as an outpatient or staying in hospital — at one of the participating treatment centres - People whose TB has been confirmed through lab tests (such as sputum examination, a test called GeneXpert, or a positive culture),...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05553236 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇿🇦 ZA

Who might be able to join this trial: - You have been diagnosed with tuberculosis (TB) that is resistant to an important TB antibiotic called rifampicin, at a facility that is part of this study - You have had a positive TB test result from a lab sample, such as a culture, smear, or a sample taken from a testing device...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05571735 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇹🇭 TH

**Who might be able to join this trial:** - Adults aged 18 and older who have been newly diagnosed with tuberculosis (TB) confirmed by laboratory tests — including both drug-sensitive and drug-resistant TB — and who are currently in the early stage of TB treatment, or healthy individuals joining as a comparison group...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05588492 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇹🇼 TW

Who might be able to join this trial: - People who have received a kidney transplant - People who will undergo a specific blood test (called an interferon-gamma release assay) to check for a latent (inactive) tuberculosis infection - People who, if that blood test comes back positive, agree to receive treatment for the...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05590455 · ANRS, Emerging Infectious Diseases Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 1 June 2027
🇧🇷 BR Mozambique Zambia

**Who might be able to join this trial:** - You are 18 years of age or older - You are living with HIV-1 (a specific type of HIV) - You have been diagnosed with, or are strongly suspected to have, tuberculosis meningitis (TB affecting the brain and surrounding membranes) - You have been receiving standard treatment for...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05610098 · University of Cape Town Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇿🇦 ZA

**Who might be able to join this trial:** - You have signed a consent form before any assessments begin and are willing to have an HIV test - You have been diagnosed with tuberculosis (TB) of the spine, based on your symptoms and imaging scans (such as an X-ray or MRI) - You are 18 years of age or older and weigh at le...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05633056 · Columbia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇿🇦 ZA

**Who might be able to join this trial:** - You have been diagnosed with tuberculosis (TB) confirmed by a lab culture or a molecular test. - You have tested positive for HIV, or have a documented history of being HIV positive. - Your TB has been found to be resistant to at least one key TB medication called rifampicin,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05655702 · ANRS, Emerging Infectious Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇻🇳 VN

Who might be able to join this trial: - People who are 18 years of age or older - People who report currently injecting heroin or any other drug - People whose urine test comes back positive for heroin or methamphetamine - People who have visible recent injection marks on their body Who may not be able to join: - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05671718 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇿🇦 ZA

**Who might be able to join this trial:** - The trial takes place at primary care clinics in KwaZulu-Natal, Gauteng, and Eastern Cape provinces in South Africa that fall within selected hospital areas - The clinics involved must have the support of provincial TB program managers, hospital leadership, and the clinic's...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05730283 · Kevin Winthrop Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 29 February 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give their own informed consent by signing and dating the consent form, without needing a legal representative to do so on their behalf. - People who are willing and able to follow the study procedures and attend all required visits for the full durati...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05756582 · Eleonora Nucera Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇮🇹 IT

Who might be able to join this trial: - People who work as healthcare workers at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome - Students enrolled in any degree program (three-year, single-cycle, master's, or graduate school) in the Faculty of Medicine and Surgery at the Catholic University of Sacred He...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05797649 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
Hong Kong

Who might be able to join this trial: - People who are currently in hospital with heart failure and fluid build-up around the lungs (pleural effusion) - People for whom a procedure to remove and test the fluid around the lungs has already been recommended as part of their care - People aged 18 years or older Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05807399 · Michael Hoelscher Phase 2 · 6 countries Recruiting
Recruiting Phase 2 Est. completion 31 October 2027
Gabon Malawi Mozambique🇿🇦 ZA Tanzania Uganda

**Who might be able to join this trial:** - People who are able to give written consent to participate, including consent for HIV testing, before any trial procedures begin. - People aged between 18 and 65 years old (inclusive). - People who weigh between 40 and 90 kg (measured in light clothing without shoes). - Peop...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05824871 · Shanghai Jiatan Pharmatech Co., Ltd Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 22 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - Your body weight is between 40kg and 90kg, and your body mass index (BMI) is between 15.0 and 28.0 (a measure of weight relative to height) - You have been diagnosed with tuberculosis (TB) that has been shown through testing to be resistant to at least the drug rifampicin, w...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05842161 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇿🇦 ZA

**Who might be able to join this trial:** - People aged 18 or older - People who are willing and able to sign a written consent form - People living with HIV (confirmed through medical records) who are currently on HIV treatment, and/or people who have started or restarted tuberculosis (TB) treatment within the last mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05916638 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2029
🇫🇷 FR

Who might be able to join this trial: - People who are older than 18 years of age, either male or female - People who have been diagnosed with both sarcoidosis and tuberculosis - People who are covered by medical insurance Who may not be able to join: - People who have an HIV infection - Women who are pregnant or brea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05917210 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 April 2028
Uganda

Who might be able to join this trial: - People who are 18 years of age or older - People who are registered in a national tuberculosis (TB) treatment program as a new, returning, previously treatment-failed, or previously lost-to-follow-up TB case - People who have been screened and invited to join the trial within 30...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05941052 · University of California, San Francisco Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
Nigeria🇵🇭 PH Zambia

**Who might be able to join this trial:** **For people being checked for tuberculosis (TB):** - Adults and young people aged 12 or older who are not currently admitted to a hospital, and who have had a cough lasting 2 weeks or more - People aged 12 or older who are not hospitalised and who have HIV, report having been...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05947890 · HIV Vaccine Trials Network Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 5 April 2027
🇿🇦 ZA

**Who might be able to join this trial:** - People aged 12 to 55 years old on the day they enroll. - People who are able to attend a participating trial clinic and are willing to be followed for the full length of the study. - People aged 18 and over who are able and willing to sign their own consent form agreeing to...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05989802 · University of California, San Francisco Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
Mozambique🇿🇦 ZA Uganda

**Who might be able to join this trial:** *For children (under 15 years old):* - Children who have 2 or more of the following: an unexplained cough of any length of time, known contact with someone who has TB or a positive TB skin test or TB blood test, or an abnormal chest X-ray of any kind - Children who have at lea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06017843 · Centre for Global Public Health Pakistan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2024
🇵🇰 PK

Who might be able to join this trial: - Anyone who is older than 15 years of age and visiting the camp sites where the trial is taking place - People who have previously had tuberculosis (TB) disease Who may not be able to join: - Children and young people who are under 15 years of age - Women who are currently pregna...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06022146 · Huashan Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are 13 years old or older and weigh at least 30 kg (about 66 lbs) - You are currently a student (junior high, senior high, or university) or a staff member registered at a school - You have had close contact with someone at your school who has been diagnosed with active t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06033807 · Huashan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇨🇳 CN

Who might be able to join this trial: - People who are 13 years of age or older - People who are currently enrolled in junior middle school, high school, or university - People who have been in close contact with a school classmate or dormitory member who has been diagnosed with active tuberculosis (for example, sharin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06057519 · Radboud University Medical Center Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇮🇹 IT🇳🇱 NL

Who might be able to join this trial: - The person has agreed to take part and signed a consent form before any trial-related procedures begin. - The person has been diagnosed with pulmonary tuberculosis (TB that affects the lungs) according to local diagnostic guidelines. - The person is 18 years of age or older at th...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06113861 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
Bolivia

Who might be able to join this trial: - Children who are being seen by a doctor because they have breathing or respiratory symptoms and tuberculosis (TB) is suspected, based on Bolivian Ministry of Health guidelines for possible TB cases in children Who may not be able to join: - Children who have been treated for TB...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06114628 · University College, London Phase 2 · 5 countries Recruiting
Recruiting Phase 2 Est. completion 24 February 2027
Moldova🇿🇦 ZA Tanzania Uganda🇻🇳 VN

Who might be able to join this trial: - People aged 18 or older at the time of screening (or above the legal age of consent in the country where the trial is taking place, if that age is higher than 18) - People who show signs of active tuberculosis (TB), either through symptoms that suggest TB in the lungs, or through...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06127641 · Centro Universitário Augusto Motta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇧🇷 BR

**Who might be able to join this trial:** - You have lung disease that developed after having tuberculosis, your condition is currently stable, and you are able to complete more than 80% of the exercise training sessions in the program. **Who may not be able to join:** - You have other health conditions that are not r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06144996 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2050
🇨🇦 CA

Who might be able to join this trial: - You are 18 years of age or older - You have been diagnosed with bronchiectasis (a lung condition where the airways are permanently widened) that is NOT caused by cystic fibrosis - You have been diagnosed with Nontuberculous Mycobacteria (NTM), which is a type of bacterial lung in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06153069 · Huashan Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 November 2027
🇨🇳 CN

Who might be able to join this trial: - You are between 14 and 80 years old - You are male or female - You are willing to sign a consent form (or, if under 18, a parent/guardian can give consent on your behalf) - A sample from your airway or lungs (such as sputum, fluid, or tissue) has tested positive for tuberculosis...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06192160 · National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 · 14 countries Recruiting
Recruiting Phase 2 Est. completion 11 November 2026
Botswana🇧🇷 BR Haiti🇮🇳 IN Kenya Malawi🇲🇽 MX🇵🇪 PE +6 more

**Who might be able to join this trial:** - People diagnosed with pulmonary (lung) tuberculosis (TB) who have either never been treated for TB before, or who completed TB treatment more than 2 years ago, with a positive sputum (mucus/phlegm) test result showing a medium or high level of TB bacteria within the last 7 d...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06199921 · Obafemi Awolowo University Teaching Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2026
Nigeria

**Who might be able to join this trial:** - People who are suspected of having pulmonary tuberculosis (TB in the lungs) AND have had at least one sputum (mucus/phlegm) sample come back positive for TB bacteria — either through a standard smear test or through a specific lab test called Xpert MTB/RIF showing a "medium"...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06221488 · Beth Israel Deaconess Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇿🇦 ZA

Who might be able to join this trial: - People who are 18 years old or older - People who work as a health worker - People who are able to give informed consent (meaning they can understand and agree to take part in the study) Who may not be able to join: - People who have previously had tuberculosis (TB) or who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06253715 · Johns Hopkins University Phase 3 · 7 countries Recruiting
Recruiting Phase 3 Est. completion 30 September 2027
🇮🇳 IN🇮🇩 ID Mozambique🇿🇦 ZA Uganda Zambia Zimbabwe

**Who might be able to join this trial:** - A parent or guardian is willing and able to give written permission for the child to take part, and the child is also willing to agree to participate where required by the reviewing ethics board. - The child is under 10 years of age at the time of joining. - The child weighs...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06272812 · International AIDS Vaccine Initiative Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 31 March 2028
Kenya🇿🇦 ZA Tanzania

**Who might be able to join this trial:** - People who are between 14 and 45 years old on the first day of the study - People who have signed the required consent forms (or, for those under 18, whose parent or guardian has given written consent and the young person has also agreed to participate) - People who, in the...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06281834 · Brigham and Women's Hospital Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 February 2027
Nigeria

**Who might be able to join this trial:** - Children with HIV who are between 4 weeks and under 12 years old, whether or not they have previously taken HIV medications - Children who show no signs of active tuberculosis (TB) based on a medical check-up - Children whose TB test results came back negative, if a test was...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06289660 · Meyer Children's Hospital IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 January 2033
🇮🇹 IT

"Who might be able to join this trial: - Children and young people between 0 and 18 years old at the time they first take part - Young patients who have been diagnosed with active tuberculosis (TB, a bacterial infection usually affecting the lungs) or latent TB (carrying the TB bacteria without feeling sick), as identi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06318416 · University of Virginia Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 December 2027
Tanzania

**Who might be able to join this trial:** - You are 3 years of age or older - You have been diagnosed with active tuberculosis (TB) in the lungs that can be treated with the antibiotic rifampin, confirmed by a lab test (or, for young children who cannot cough up a sample, diagnosed using standard medical guidelines) -...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06338215 · Clinica Universidad de Navarra, Universidad de Navarra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇪🇸 ES

**Who might be able to join this trial:** - Men between the ages of 50 and 70, or women between the ages of 55 and 75 - People who currently drink alcoholic beverages, consuming at least 3 but no more than 40 drinks per week - People whose doctor estimates they have a life expectancy of more than 5 years - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06347939 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇸🇪 SE

Who might be able to join this trial: - People who have enlarged lymph nodes in the chest area (greater than 1 cm in size) - People for whom a clinical assessment and tissue sampling of these lymph nodes is already planned as part of their standard care - People who are 18 years of age or older - People who agree to ta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06352970 · Lund University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
Ethiopia

Who might be able to join this trial: - Women who have been admitted to a participating hospital or clinic to give birth - People who are 18 years of age or older - People who have given written consent to take part in the study Who may not be able to join: - People who have long-term or ongoing health conditions, oth...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06381375 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
🇪🇬 EG

Who might be able to join this trial: - People who have been diagnosed with tuberculosis and have been referred to the Tuberculosis outpatient clinic at Kasr Alainy Faculty of Medicine, Cairo University, after the study received official scientific and ethical approval. Who may not be able to join: - People who, or wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06403943 · Beijing Chest Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 65 years old, of any gender - People who have been diagnosed with pulmonary tuberculosis (TB affecting the lungs) according to a specific Chinese medical standard (WS 288-2017) - People who have either never received TB treatment before, or have received st...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06413459 · Ospedale San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2027
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with cystic fibrosis and are being seen as part of their regular medical care at a participating centre - Both men and women are eligible - People who are older than 18 years of age - People who have given their informed consent to participate, foll...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06437184 · Aarhus University Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 30 October 2025
Ethiopia Guinea-Bissau

Who might be able to join this trial: - You are 15 years old or older - You have symptoms that suggest tuberculosis (TB), such as a cough, producing mucus or phlegm, and/or losing weight (for any length of time) Who may not be able to join: - You have received treatment for TB in the past year - You have a brain or me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06439810 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Hong Kong

Who might be able to join this trial: - People who have recently developed a new build-up of fluid around the lung and are already scheduled to have a procedure to drain that fluid - People who are 18 years of age or older - People who are able to understand and agree to participate by signing a consent form Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06441006 · University of California, San Francisco Phase 3 · 5 countries Recruiting
Recruiting Phase 3 Est. completion 1 August 2031
Mongolia🇵🇰 PK🇵🇪 PE Uganda🇻🇳 VN

**Who might be able to join this trial:** - You have been diagnosed with a type of tuberculosis (TB) that is resistant to a common TB drug called rifampicin, but is still treatable with a class of antibiotics called fluoroquinolones, confirmed by a lab test. - You are 14 years old or older. - You have a stable home ad...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06446245 · National University Hospital, Singapore Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 1 November 2027
🇮🇩 ID🇲🇾 MY🇸🇬 SG

**Who might be able to join this trial:** - You are 21 years of age or older. - You have either just started TB treatment (within the last 7 days or less) or are about to begin TB treatment. - You have been diagnosed with, or are strongly suspected to have, tuberculosis (TB) affecting the brain and/or its surrounding...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06477185 · Makerere University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 20 December 2026
Uganda

**Who might be able to join this trial:** - You are between 18 and 65 years old - You have been diagnosed with a current episode of pulmonary tuberculosis (TB in the lungs), confirmed by a sputum test or a GeneXpert test showing the TB is not resistant to the antibiotic rifampicin - Your chest X-ray shows TB affecting...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06484530 · Mahidol University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 18 September 2024
🇹🇭 TH

**Who might be able to join this trial:** - You are between 18 and 80 years old. - You have been recently diagnosed with tuberculosis (TB), whether it affects the lungs or another part of the body. - You are receiving the standard TB treatment medications (following one of two standard treatment plans). - You are willi...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06485895 · Assistance Publique Hopitaux De Marseille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2027
🇫🇷 FR

Who might be able to join this trial: - People who are at least 18 years old - People who are currently receiving treatment for tuberculosis (TB) disease - People who have had a specific type of TB screening blood test (called an IGRA test) ordered by a doctor, either already completed or currently being done - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06497465 · Johns Hopkins University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 January 2028
🇧🇷 BR

Who might be able to join this trial: - People who have a confirmed HIV-1 diagnosis, proven through standard HIV testing methods such as rapid tests, blood tests, or measurements of the virus in the blood. - People whose recent blood test (taken within the last 30 days) shows a CD4+ immune cell count of at least 50 cel...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06498414 · McGill University Health Centre/Research Institute of the McGill Unive... Phase 3 · 5 countries Recruiting
Recruiting Phase 3 Est. completion 1 April 2027
Benin🇧🇷 BR🇨🇦 CA🇮🇩 ID🇻🇳 VN

Who might be able to join this trial: - Adults, and children aged 5 years or older who weigh more than 15 kg (about 33 pounds) - People who have tested positive for TB infection, either through a skin test (tuberculin test) or a blood test (interferon gamma release assay), interpreted according to local guidelines - Pe...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06522347 · Ludwig Boltzmann Institute for Lung Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2053
🇦🇹 AT

Who might be able to join this trial: - People who have been diagnosed with a Mycobacterium tuberculosis infection (the bacteria that causes TB) or a non-tuberculous mycobacteria infection (a related type of bacterial infection). - People who are 18 years of age or older. - People who are willing and able to provide wr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06526689 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are between 18 and 65 years old - You live in or near London or Oxford and can stay in the area for the whole study period - You are willing to sign a consent form agreeing to take part - You are happy for the research team to look at your NHS health records, medical his...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06528418 · ChromX Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 years or older, of any gender. - People who have had a CT scan of the lungs that meets the imaging requirements for this trial, and who are able to share an electronic copy of their CT scan data. - People who have received a confirmed clinical diagnosis of a lung d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06531772 · Assiut University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
🇪🇬 EG

"Who might be able to join this trial: - People who have been diagnosed with both tuberculosis (TB) and HIV through laboratory testing Who may not be able to join: - People who do not wish to take part in the study Important: Always verify eligibility with the trial site directly before applying."

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06565845 · First Affiliated Hospital of Harbin Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 September 2024
🇨🇳 CN

**Who might be able to join this trial:** - You are between 15 and 65 years old and are not currently breastfeeding - Your condition has been confirmed by a tissue sample (biopsy) test showing a specific type of breast inflammation called GLM - Your liver and kidneys are working normally, based on recent test results...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06568484 · Johns Hopkins University Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 1 July 2027
🇵🇪 PE Tanzania Uganda

**Who might be able to join this trial:** **For the index patient (the person with tuberculosis):** - People of any age who have been confirmed with pulmonary tuberculosis (TB affecting the lungs) through laboratory testing - People who started TB treatment within the past 90 days - People who have at least one close...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06580639 · Linkoeping University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇸🇪 SE

Who might be able to join this trial: - People who are healthy blood donors - People who are scheduled to receive a vaccination Who may not be able to join: - People who have a known HIV infection - People who are not Swedish citizens - People who have a long-term (chronic) liver or kidney disease - People whose immun...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06585358 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇸🇪 SE

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with tuberculosis (TB) in the lungs, confirmed through a laboratory culture or a specific type of lab test (PCR) - People whose TB treatment includes the antibiotic rifampin, whether that treatment is already underway or being plann...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06590428 · Albert Einstein College of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇿🇦 ZA

Who might be able to join this trial: - You must be 18 years of age or older - You must have been diagnosed with a type of tuberculosis (TB) that does not respond to the antibiotic rifampicin, confirmed by a lab test - You must have started a TB treatment plan that includes the medication linezolid no more than 14 days...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06593080 · Chishala Chabala Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
Zambia

Who might be able to join this trial: - Children under 15 years old who are sick and visiting selected health facilities, whether for an outpatient appointment or staying in hospital - Children who belong to higher-risk groups, including those under 2 years old, children living with HIV, or children who are severely ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06602869 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - You must be 18 years old or older - You must have previously taken part in the CIMeNT study - You must have a confirmed diagnosis of cystic fibrosis (any genetic type) - You must be covered by the French social security system - You must be registered in the French Cystic Fib...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06618573 · Universitas Padjadjaran Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2025
🇮🇩 ID

**Who might be able to join this trial:** - You have been diagnosed with Systemic Lupus Erythematosus (SLE, also known as lupus) - You currently have no signs or symptoms of active tuberculosis (TB) - You are not currently being treated for TB - You have no past history of TB, cancer, HIV, or liver problems - You are n...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06629194 · Mahidol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇹🇭 TH

**Who might be able to join this trial:** - You are 18 years of age or older - You had a colonoscopy that found ulcers in your small intestine (ileum) or large intestine (colon) - Tissue samples from your intestine were tested for tuberculosis bacteria, including a stain test, a DNA test (PCR), and a culture (growing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06700876 · Mahidol University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇭 TH

Who might be able to join this trial: - People who have end-stage kidney disease and are currently receiving dialysis (either hemodialysis or peritoneal dialysis), or who have previously received a kidney transplant from either a living or deceased donor. - People who are 18 years of age or older. Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06702774 · University of Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2025
🇨🇳 CN

Who might be able to join this trial: - People aged 65 or older who live in the area where the trial is taking place - People aged 15 to 64 who live in the area and have previously been treated for tuberculosis (TB), or have had close contact with someone diagnosed with TB in the last three years - People aged 15 to 64...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06706596 · Fundació Institut Germans Trias i Pujol Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

Who might be able to join this trial: - You belong to a group of people who are considered at high risk of getting tuberculosis (TB) (confirm with trial site what groups are included) Who may not be able to join: - You do not belong to a group of people considered at high risk of getting tuberculosis (TB) Important:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06714513 · Quratis Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who are able to attend all required visits during the trial and can be contacted by the research team throughout. - People who are between 55 and 74 years old at the time of giving consent. - People (or their legal representatives) who are able to sign a consent form...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06719193 · Management Sciences for Health Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2025
Ethiopia

Who might be able to join this trial: - Adults aged 18 or older who give their own consent to take part - Adults who live within the designated study area (woreda) - Young people aged 12 to 17 who agree to take part and whose guardian also gives consent on their behalf - Young people aged 12 to 17 who live within the...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06727864 · Kaohsiung Veterans General Hospital. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2027
🇹🇼 TW

**Who might be able to join this trial:** - You have recently been diagnosed with tuberculosis (TB) in your lungs, confirmed by a lab test, tissue sample, or a doctor's clinical assessment - You had TB in the past but were fully cured at least 3 years ago - You are 21 years old or older - Your recent blood tests (take...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06748937 · TASK Applied Science Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2026
🇿🇦 ZA

Who might be able to join this trial: - People who are willing to give written consent and follow all study procedures for the full duration of the trial. - People aged between 18 and 65 years old (inclusive), of any gender. - People who weigh between 40 and 90 kg (measured in light clothing, without shoes). - People w...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06764576 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

Who might be able to join this trial: - You must be 18 years old or older. - You must be suspected, based on symptoms or medical imaging, of having tuberculosis (TB), a related type of mycobacterial infection, or a condition called ITBL (confirm with trial site), and at least one body sample (such as sputum, tissue, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06796647 · Chinese University of Hong Kong Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇨🇳 CN Hong Kong

Who might be able to join this trial: - Adults aged 18 to 65 years old - People who have been diagnosed with at least one recognised rheumatological (joint or immune-related) disease - People whose doctor has planned for them to start a type of medication known as b/tsDMARDs (a category of stronger disease-modifying tr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06815588 · Research Center Borstel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇷🇴 RO

**Who might be able to join this trial:** - The child must be under 15 years old and being assessed for tuberculosis (TB) that affects the lungs or breathing. - A parent or guardian must be willing to sign a consent form agreeing to take part, and the child may also need to sign an agreement form if they are old enough...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06845618 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇹🇭 TH

Who might be able to join this trial: **For people newly diagnosed with tuberculosis (TB):** - Adults aged 18 or older - People who have been recently confirmed as having a TB infection through a lab test (either a culture test or a nucleic acid amplification test), at any location in the body - People who have not ye...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06875336 · University of Cologne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇩🇪 DE

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have had tuberculosis (TB) bacteria identified from a body fluid or tissue sample through a lab test (such as PCR or culture), or who have been clinically diagnosed with TB based on exposure history, physical examination, i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06893757 · ANRS, Emerging Infectious Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years old or older. - You have been diagnosed with tuberculosis (TB) — either confirmed by lab tests or assessed by a doctor based on symptoms or tissue examination — and have been receiving treatment for fewer than 8 days. - You have signed a voluntary, informed,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06905522 · Shenzhen Third People's Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2029
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 65 years old, of any gender - People whose symptoms and/or chest X-ray or CT scan results support a diagnosis of active pulmonary (lung) tuberculosis (TB) - People whose TB has been confirmed by laboratory testing (such as a test called GeneXpert),...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06909799 · The Aurum Institute NPC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
The Gambia

Who might be able to join this trial: - Adults between 18 and 65 years of age. - People who are willing and able to give signed written consent, or witnessed spoken consent with a thumbprint if they cannot read or write, before any trial procedures begin. - People whose body weight (measured in light clothing without s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06916962 · Freundeskreis Für Internationale Tuberkulosehilfe e.V Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇻🇳 VN

**Who might be able to join this trial:** - You have been diagnosed with a type of tuberculosis (TB) that can be treated with standard TB medicines (not drug-resistant TB), affecting the lungs, and it is either a new diagnosis or a return of a previous TB infection - You have already started TB treatment and your case...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06946784 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇰🇷 KR

Who might be able to join this trial: - You are 19 years old or older - You have been diagnosed with tuberculosis (TB) in your lungs, and you are either about to start treatment, currently on treatment, or have previously completed treatment for it Who may not be able to join: - You are younger than 19 years old - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06963606 · Xuelin Yang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who receive medical care at a primary healthcare hospital in Yichang City, Hubei Province, China, and have had a chest X-ray taken there - People who are older than 15 years of age - People who have respiratory symptoms or signs that may be related to tuberculosis - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06971952 · University of Virginia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
Tanzania

Who might be able to join this trial: - People who have been diagnosed with drug-sensitive pulmonary tuberculosis (a type of TB affecting the lungs that responds to standard TB medicines) and who have started TB treatment within the last 2 months - People who live within the area served by Haydom Lutheran Hospital - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07018076 · University of California, San Francisco Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
Uganda🇻🇳 VN

Who might be able to join this trial: - You are 12 years old or older - You have finished a standard 6-month course of tuberculosis (TB) treatment, which included four specific medicines: isoniazid, rifampin, pyrazinamide, and ethambutol Who may not be able to join: - You finished your TB treatment more than 14 days b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07024836 · University College, London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are 18 years old or older and have recently been tested for a hidden (inactive) TB infection as part of normal healthcare, or you qualify to be tested for it - You are a migrant who came to the UK from a country where TB is common, and you arrived within the last 5 years...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07073638 · Thirty Respiratory Limited Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 September 2026
🇿🇦 ZA

**Who might be able to join this trial:** - People who are willing to sign a consent form and take part in all parts of the trial - People who weigh between 40 and 90 kg (measured in light clothing, without shoes) - People who have been recently diagnosed with pulmonary tuberculosis (TB affecting the lungs) - People w...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07077213 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older - Your tuberculosis (TB) has been confirmed by a lab culture or a positive sputum (mucus) test using a specific molecular testing method called GeneXpert - Scans or images (such as chest X-ray, CT scan, MRI, ultrasound, PET/CT, or bone scan) show...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07086820 · Pontificia Universidad Catolica de Chile Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇨🇱 CL

**Who might be able to join this trial:** - You live in the same household as someone who has recently been diagnosed with a confirmed case of tuberculosis (TB) in their lungs - You are between 5 and 17 years old (at least 5, but not yet 18) **Who may not be able to join:** - You show signs of having active TB yoursel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07097961 · University of Iowa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 February 2026
Uganda

Who might be able to join this trial: - You are between 6 and 17 years old - You have previously been diagnosed with lung disease caused by tuberculosis (TB) - You are able and willing to stay in the local study area for the whole duration of the study - You are able to take part in light to moderate physical activity...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07117370 · Arizona State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇿🇦 ZA

**Who might be able to join this trial:** *(Note: This trial has two parts — Aim 2 and Aim 3 — each with slightly different requirements)* **For Aim 2:** - You identify as a man - You are 18 years old or older - You are starting tuberculosis (TB) treatment for the first time, or restarting it after having stopped and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07119359 · University of Washington Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2029
Uganda

**Who might be able to join this trial:** - You either have pulmonary tuberculosis (TB, a lung infection) yourself, or you live in the same household as someone who has pulmonary TB and is currently receiving treatment at one of the participating clinics or health facilities - Your household has at least 2 people livin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07125274 · Research Center Borstel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇪 DE

Who might be able to join this trial: - People who are suspected of having tuberculosis (TB) in the lungs or elsewhere in the body, or who have a confirmed TB diagnosis but have been on TB treatment for fewer than 7 days, or who have another type of lung infection (for the control group). - People who are 18 years of a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07131774 · Research Center Borstel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇩🇪 DE

**Who might be able to join this trial:** - People who have a lung infection caused by non-tuberculous mycobacteria (NTM), diagnosed according to recognised international medical guidelines - People who are 18 years of age or older - People who are able to understand and agree to take part in the study - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07152639 · Chengdu CoenBiotech Co., Ltd Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 May 2026
🇨🇳 CN

**Who might be able to join this trial:** *General community members (no tuberculosis history):* - People aged 3 years or older, of any gender - People (or their guardian) who agree to take part and sign a consent form - People (or their guardian) who are able to attend follow-up visits as required by the trial - Peop...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07155954 · Peking University Third Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 October 2027
🇨🇳 CN

Who might be able to join this trial: - Ultrasound results have shown that one or more lymph nodes appear abnormal - A biopsy procedure (such as a needle sample or surgery) on the lymph node is already planned - The person is 18 years of age or older Who may not be able to join: - Women who are pregnant or currently b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07164742 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2028
🇮🇳 IN

**Who might be able to join this trial:** - You are 18 years of age or older - You have been confirmed to have TB in your lungs through a lab test (such as a sputum smear, GeneXpert test, or culture) - You have not been on TB treatment for more than 2 weeks at the time of joining - You are receiving your TB care at one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07170735 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
Hong Kong

Who might be able to join this trial: - People who have been hospitalised with a newly diagnosed tuberculosis (TB) infection - People who do not have active TB but have been diagnosed with a latent TB infection (meaning the TB bacteria is present in the body but not causing illness), confirmed by either a skin test or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07170800 · WestVac Biopharma Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 28 February 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 14 to 65 years, male or female - People who weigh between 40 kg and 90 kg - People who have been clinically confirmed to have pulmonary tuberculosis (TB) that has been tested and shown to be resistant to at least the antibiotic rifampicin, with those test results...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07178860 · Liverpool School of Tropical Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇬🇧 GB

Who might be able to join this trial: - You must be 18 years old or older - You must be able to read and sign a consent form agreeing to take part - You must have previously been diagnosed with pulmonary (lung) tuberculosis (TB) that was confirmed by laboratory tests - You must have finished your TB treatment 18 months...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07192705 · University College, London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇬🇧 GB

**Who might be able to join this trial:** - You must be 18 years old or older and able to agree to take part in the study yourself. **If joining as someone with a non-tuberculous mycobacteria lung disease (NTM-PD):** - You have been formally diagnosed with NTM lung disease according to recognised medical guidelines,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07209761 · Otsuka Pharmaceutical Development & Commercialization, Inc. Phase 3 · 8 countries Recruiting
Recruiting Phase 3 Est. completion 28 May 2027
🇨🇳 CN🇬🇪 GE🇯🇵 JP Moldova🇵🇪 PE🇵🇭 PH🇿🇦 ZA🇰🇷 KR

**Who might be able to join this trial:** - People aged 14 years or older - People weighing at least 30 kg - People who are able to sign a written consent form (for those under 18, both the young person's agreement and a parent or guardian's consent are required) - People with a confirmed lung tuberculosis (TB) diagno...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07213765 · Bin Cao Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2028
🇨🇳 CN

Who might be able to join this trial: - You are willing to take part in the study and agree to sign a consent form. - You are between 18 and 75 years old (any gender). - You have been diagnosed with a specific type of lung disease caused by a bacteria called MAC (Mycobacterium avium complex), confirmed using establishe...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07271225 · Indonesia University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇩 ID

**Who might be able to join this trial:** - People who have been diagnosed with either drug-sensitive tuberculosis or drug-resistant tuberculosis and are currently on a short-term treatment regimen known as BPaL or BPaLM - People who are 17 years of age or older - People who experience nausea and vomiting after taking...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07303699 · Obafemi Awolowo University Teaching Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 March 2027
Nigeria

**Who might be able to join this trial:** - Your sputum (mucus/phlegm) test came back positive for TB bacteria, confirmed by either a Gene Xpert test or a microscope test - You have either never been treated for TB before, or you have taken TB medication for less than 2 weeks - You are aged 12 years or older - You hav...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07312266 · Barcelona Institute for Global Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
Mozambique

Who might be able to join this trial: **For people living with HIV (called "index cases"):** - You are 18 years old or older - You have a confirmed HIV diagnosis - You are visiting a health facility for your regular HIV care **For Study 3 specifically, you also need to meet these additional conditions:** - You have b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07369414 · Research Center Borstel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇩🇪 DE

Who might be able to join this trial: - People who have a confirmed diagnosis of cystic fibrosis (CF) - People of any age, including children (with consent provided by a parent or legal guardian) - People for whom written consent to take part in the study has been given (either by the person themselves, or by a parent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07387601 · Bahirdar University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 July 2026
Ethiopia

Who might be able to join this trial: - Adults who have been newly diagnosed with drug-susceptible pulmonary tuberculosis (TB that responds to standard TB medicines, affecting the lungs), confirmed through laboratory testing methods - People who are not currently taking part in a similar study - People who are mentally...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07395596 · First Affiliated Hospital of Zhejiang University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been classified by your doctor as having significant health conditions that pose moderate to high risk during procedures (known as ASA Class III or IV) (confirm with trial site) - You are already scheduled to have a planned, non-emergency bronchoscopy (a procedure to...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07451899 · Universitas Padjadjaran Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇮🇩 ID

Who might be able to join this trial: - You are between 10 and 18 years old - A doctor (pediatrician) has diagnosed you with lung disease that developed after having tuberculosis - You are physically able to complete a 6-minute walk test, which involves walking as far as you can in 6 minutes Who may not be able to joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07477119 · Marco Schiuma Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2027
Guinea

Who might be able to join this trial: - You have been diagnosed with a type of tuberculosis (TB) that is resistant to multiple standard antibiotics (known as MDR-TB). - Your doctor has prescribed a specific combination of medicines that includes a drug called linezolid (as part of a treatment plan called BPaL or BPaL-M...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07484490 · Riphah International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇵🇰 PK

Who might be able to join this trial: - Children who are between 8 and 14 years old - Children who have been diagnosed with tuberculosis (TB) - Children who have too much mucus in their lungs or have trouble coughing up and clearing mucus from their airways - Children who are able to understand and follow spoken instru...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07517445 · Gates Medical Research Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 14 June 2027
🇿🇦 ZA

**Who might be able to join this trial:** - You are between 18 and 65 years old at the time of signing the consent form - You weigh between 40 and 100 kg at the time of your screening appointment - You are willing and able to sign a written consent form to participate - You have been newly diagnosed with tuberculosis (...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07525427 · Gates Medical Research Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 5 November 2026
🇿🇦 ZA

Who might be able to join this trial: - People aged 18 to 65 years old at the time of giving consent - People weighing between 35 and 100 kg at the screening visit - People who have given written consent to take part - People newly diagnosed with pulmonary tuberculosis (TB in the lungs) that is sensitive to the antibio...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07575061 · Beijing Chest Hospital, Capital Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who were 18 years of age or older at the time they were diagnosed with intestinal tuberculosis (there is no upper age limit) - People who have been diagnosed with intestinal tuberculosis based on symptoms, test results, scans, and/or tissue examination results - For t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07638670 · First Affiliated Hospital of Ningbo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 July 2026
🇨🇳 CN

Who might be able to join this trial: - You must be 18 years of age or older; people of all genders and races are welcome. - You have been recently diagnosed with active tuberculosis (TB) in the lungs, either through a clinical diagnosis or a procedure called bronchoscopy, within the last week. - You have a latent (hid...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07672405 · Global Alliance for TB Drug Development Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 28 May 2027
🇿🇦 ZA Tanzania

**Who might be able to join this trial:** - People diagnosed with a type of tuberculosis (TB) that responds to the standard TB medicines rifampicin and isoniazid, confirmed by a sputum (mucus) test, AND who are either newly diagnosed with TB or have not received any TB treatment for at least 3 years after being cured o...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07708779 · University Medical Center Groningen Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 16 July 2026
🇳🇱 NL

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with tuberculosis (TB) where the specific type of TB and how it responds to medicines is already known, confirmed through lab culture or molecular testing - People whose condition is stable or getting better...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Tuberculosis. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

There's no dedicated Australian organisation for tuberculosis. It's managed mainly through state and territory TB services instead.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.